Cargando…

Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath

Introduction: We studied the trend of antimicrobial resistance and consumption at Saint George Hospital University Medical Center (SGHUMC), a tertiary care center in Beirut, Lebanon, with a focus on the SARS-CoV-2 pandemic. Materials and Methods: We calculated the isolation density/1000 patient-days...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamieh, Amanda, Zgheib, Rita, El-Sawalhi, Sabah, Yammine, Laure, El-Hajj, Gerard, Zmerli, Omar, Afif, Claude, Rolain, Jean-Marc, Azar, Eid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388970/
https://www.ncbi.nlm.nih.gov/pubmed/34439065
http://dx.doi.org/10.3390/antibiotics10081016
_version_ 1783742755327967232
author Chamieh, Amanda
Zgheib, Rita
El-Sawalhi, Sabah
Yammine, Laure
El-Hajj, Gerard
Zmerli, Omar
Afif, Claude
Rolain, Jean-Marc
Azar, Eid
author_facet Chamieh, Amanda
Zgheib, Rita
El-Sawalhi, Sabah
Yammine, Laure
El-Hajj, Gerard
Zmerli, Omar
Afif, Claude
Rolain, Jean-Marc
Azar, Eid
author_sort Chamieh, Amanda
collection PubMed
description Introduction: We studied the trend of antimicrobial resistance and consumption at Saint George Hospital University Medical Center (SGHUMC), a tertiary care center in Beirut, Lebanon, with a focus on the SARS-CoV-2 pandemic. Materials and Methods: We calculated the isolation density/1000 patient-days (PD) of the most isolated organisms from 1 January 2015–31 December 2020 that included: E. coli (Eco), K. pneumoniae (Kp), P. aeruginosa (Pae), A. baumannii (Ab), S. aureus (Sau), and E. faecium (Efm). We considered March–December 2020 a surrogate of COVID-19. We considered one culture/patient for each antimicrobial susceptibility and excluded Staphylococcus epidermidis, Staphylococcus coagulase-negative, and Corynebacterium species. We analyzed the trends of the overall isolates, the antimicrobial susceptibilities of blood isolates (BSI), difficult-to-treat (DTR) BSI, carbapenem-resistant Enterobacteriaceae (CRE) BSI, and restricted antimicrobial consumption as daily-defined-dose/1000 PD. DTR implies resistance to carbapenems, beta-lactams, fluoroquinolones, and additional antimicrobials where applicable. Results and Discussion: After applying exclusion criteria, we analyzed 1614 blood cultures out of 8314 cultures. We isolated 85 species, most commonly Eco, at 52%. The isolation density of total BSI in 2020 decreased by 16%: 82 patients were spared from bacteremia, with 13 being DTR. The isolation density of CRE BSI/1000 PD decreased by 64% from 2019 to 2020, while VREfm BSI decreased by 34%. There was a significant decrease of 80% in Ab isolates (p-value < 0.0001). During COVID-19, restricted antimicrobial consumption decreased to 175 DDD/1000 PD (p-value < 0.0001). Total carbapenem consumption persistently decreased by 71.2% from 108DDD/1000 PD in 2015–2019 to 31 DDD/1000 PD in 2020. At SGHUMC, existing epidemics were not worsened by the pandemic. We attribute this to our unique and dynamic collaboration of antimicrobial stewardship, infection prevention and control, and infectious disease consultation.
format Online
Article
Text
id pubmed-8388970
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83889702021-08-27 Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath Chamieh, Amanda Zgheib, Rita El-Sawalhi, Sabah Yammine, Laure El-Hajj, Gerard Zmerli, Omar Afif, Claude Rolain, Jean-Marc Azar, Eid Antibiotics (Basel) Article Introduction: We studied the trend of antimicrobial resistance and consumption at Saint George Hospital University Medical Center (SGHUMC), a tertiary care center in Beirut, Lebanon, with a focus on the SARS-CoV-2 pandemic. Materials and Methods: We calculated the isolation density/1000 patient-days (PD) of the most isolated organisms from 1 January 2015–31 December 2020 that included: E. coli (Eco), K. pneumoniae (Kp), P. aeruginosa (Pae), A. baumannii (Ab), S. aureus (Sau), and E. faecium (Efm). We considered March–December 2020 a surrogate of COVID-19. We considered one culture/patient for each antimicrobial susceptibility and excluded Staphylococcus epidermidis, Staphylococcus coagulase-negative, and Corynebacterium species. We analyzed the trends of the overall isolates, the antimicrobial susceptibilities of blood isolates (BSI), difficult-to-treat (DTR) BSI, carbapenem-resistant Enterobacteriaceae (CRE) BSI, and restricted antimicrobial consumption as daily-defined-dose/1000 PD. DTR implies resistance to carbapenems, beta-lactams, fluoroquinolones, and additional antimicrobials where applicable. Results and Discussion: After applying exclusion criteria, we analyzed 1614 blood cultures out of 8314 cultures. We isolated 85 species, most commonly Eco, at 52%. The isolation density of total BSI in 2020 decreased by 16%: 82 patients were spared from bacteremia, with 13 being DTR. The isolation density of CRE BSI/1000 PD decreased by 64% from 2019 to 2020, while VREfm BSI decreased by 34%. There was a significant decrease of 80% in Ab isolates (p-value < 0.0001). During COVID-19, restricted antimicrobial consumption decreased to 175 DDD/1000 PD (p-value < 0.0001). Total carbapenem consumption persistently decreased by 71.2% from 108DDD/1000 PD in 2015–2019 to 31 DDD/1000 PD in 2020. At SGHUMC, existing epidemics were not worsened by the pandemic. We attribute this to our unique and dynamic collaboration of antimicrobial stewardship, infection prevention and control, and infectious disease consultation. MDPI 2021-08-21 /pmc/articles/PMC8388970/ /pubmed/34439065 http://dx.doi.org/10.3390/antibiotics10081016 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chamieh, Amanda
Zgheib, Rita
El-Sawalhi, Sabah
Yammine, Laure
El-Hajj, Gerard
Zmerli, Omar
Afif, Claude
Rolain, Jean-Marc
Azar, Eid
Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath
title Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath
title_full Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath
title_fullStr Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath
title_full_unstemmed Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath
title_short Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath
title_sort trends of multidrug-resistant pathogens, difficult to treat bloodstream infections, and antimicrobial consumption at a tertiary care center in lebanon from 2015–2020: covid-19 aftermath
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388970/
https://www.ncbi.nlm.nih.gov/pubmed/34439065
http://dx.doi.org/10.3390/antibiotics10081016
work_keys_str_mv AT chamiehamanda trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath
AT zgheibrita trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath
AT elsawalhisabah trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath
AT yamminelaure trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath
AT elhajjgerard trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath
AT zmerliomar trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath
AT afifclaude trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath
AT rolainjeanmarc trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath
AT azareid trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath